Filter
964
Text search:
drug-resistance
infections
Featured
Recommendations
102
New Publications
287
Language
Document type
No document type
634
Studies & Reports
129
Guidelines
123
Manuals
26
Strategic & Response Plan
23
Fact sheets
10
Training Material
9
Situation Updates
6
Infographics
4
Countries / Regions
India
54
Ethiopia
28
South Africa
28
Tanzania
27
Western and Central Europe
26
Nepal
25
Kenya
24
Eastern Europe
19
Zambia
18
Malawi
18
Africa
18
Uganda
15
Namibia
15
Asia
15
Nigeria
14
Ghana
14
Cambodia
13
Sierra Leone
11
Liberia
11
Rwanda
10
Lesotho
10
Latin America and the Carribbean
10
Russia
10
Zimbabwe
9
Bangladesh
9
Myanmar / Burma
9
South–East Asia Region
8
Ukraine
7
Global
7
Philippines
6
Botswana
6
Senegal
5
Cameroon
5
Pakistan
5
Eswatini/ Swaziland
5
Mozambique
4
East and Southern Africa
4
Albania
4
Burkina Faso
3
Indonesia
3
West and Central Africa
3
Middle East and North Africa
3
Venezuela
3
Vietnam
3
Guinea
2
Haiti
2
Afghanistan
2
Thailand
2
China
2
Sri Lanka
2
Western Pacific Region
2
Laos
2
Georgia
2
Gabon
2
Congo, Democratic Republic of
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
South Sudan
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Gambia
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Brazil
1
Serbia
1
Eastern Europe and Central Asia
1
Paraguay
1
Bhutan
1
Armenia
1
Timor Leste/ East Timor
1
Tajikistan
1
Estonia
1
Iran
1
Turkmenistan
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
359
Clinical Guidelines
109
Public Health
30
Women & Child Health
21
Pharmacy & Technologies
17
Capacity Building
8
Key Resources
7
Toolboxes
TB
191
HIV
188
AMR
143
NTDs
23
Pharmacy
17
Planetary Health
12
Polio
9
Ebola
8
Global Health Education
8
Rapid Response
7
Refugee
7
Caregiver
7
COVID-19
6
Natural Hazards
3
Mental Health
3
Health Financing Toolbox
3
NCDs
3
Cholera
2
Conflict
2
Disability
1
Zika
1
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from
...
This Tailoring Antimicrobial Resistance Programmes (TAP) process assists Member States in initiating and undertaking projects to address the spread of antimicrobial resistance (AMR) in their countries. AMR is a complex problem requiring unique, context-specific solutions. This TAP Toolbo
...
Cities are uniquely positioned to understand local needs and respond rapidly to changing conditions to safeguard health. These changes require strong city leadership to implement multisectoral, health-relevant policies and public services that engage communities. The response to malaria must be an i
...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions
...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT
...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act
...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti
...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t
...
Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because of the impact of epilepsy on wages, health costs and social stigmatization of sufferers.
...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci
...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e
...
This annual report gives an overview of WHO lesotho Country office's undertakings and achievements in the context of an extraordinary health emergency. As we walk another mile this year, may we embrace all lessonst leanred in the previous year, learn from what did not work so well and take on new op
...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The
...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p
...
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and
...
This report summarizes the World Health Organization’s (WHO) global work on water, sanitation and hygiene (WASH) during 2022. It describes how the Organization continued to deliver its essential WASH programming as elaborated in its 2018–2025 strategy.
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of
...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa
...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the
...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
